Metly — Pre-seed · €520K

Metly, an AI platform for pharmaceutical business development teams that surfaces licensing and manufacturing opportunities and connects potential partners, closed an oversubscribed pre-seed round of €520,000 led by Encomenda. The platform already tracks over 35,000 licences from more than 550 companies and will use the capital to scale its technology and expand into the US and China.